Perseus is a merchant bank and private equity fund management company.
Business Model:
Revenue: $17.3M
Employees: 2-10
Address: 2099 Pennsylvania Ave NW
City: Washington
State: district of columbia
Zip: 20006
Country: US
Contact Phone:
+12024520101
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
10/2001 | Biometric Access | Series B | 12M |
3/2002 | SoftSwitching Technologies | Series C | 17M |
4/2005 | Iridian Technologies | Series C | 5M |
3/2003 | Evergreen Solar | Post-IPO Equity | 0 |
8/2008 | Vehicle Production Group | Private Equity Round | 0 |
11/2012 | BlueWillow Biologics | Series C | 0 |
4/2003 | Serveron | Venture Round | 0 |
10/2001 | Encorp | Series D | 0 |
7/2000 | ClubMom | Series B | 0 |
3/2004 | Serveron | Venture Round | 0 |
2/2009 | BlueWillow Biologics | Series B | 0 |
10/2006 | BlueWillow Biologics | Series A | 30M |
8/2010 | Metamark Genetics | Series B | 0 |
8/2010 | CeNeRx BioPharma | Series C | 0 |
6/2001 | Serveron | Venture Round | 0 |
7/2009 | BlueWillow Biologics | Series B | 0 |
11/2009 | Lumexis | Venture Round | 0 |
9/2008 | SoftSwitching Technologies | Series E | 0 |
3/2007 | Serveron | Series G | 0 |
1/2006 | Serveron | Series F | 0 |
4/2007 | Bioenvision | Venture Round | 7.4M |
3/2007 | MAP Pharmaceuticals | Series D | 50M |
1/2006 | MAP Pharmaceuticals | Series C | 25.2M |
1/2010 | Cymbet | Series C | 0 |
4/2007 | Ascenta Therapeutics | Series C | 50M |
11/2012 | BlueWillow Biologics | Series C | 0 |
8/2010 | Metamark Genetics | Series B | 0 |
8/2010 | CeNeRx BioPharma | Series C | 0 |
1/2010 | Cymbet | Series C | 0 |
11/2009 | Lumexis | Venture Round | 0 |
7/2009 | BlueWillow Biologics | Series B | 0 |
2/2009 | BlueWillow Biologics | Series B | 0 |
9/2008 | SoftSwitching Technologies | Series E | 0 |
8/2008 | Vehicle Production Group | Private Equity Round | 0 |
4/2007 | Bioenvision | Venture Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|